Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Total Valuation
Britannia Life Sciences Inc has a market cap or net worth of C$14.60M. The enterprise value is C$13.03M.
Market CapC$14.60M
Enterprise ValueC$13.03M
Share Statistics
Britannia Life Sciences Inc has 162,254,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding162,254,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Britannia Life Sciences Inc’s return on equity (ROE) is 1.17 and return on invested capital (ROIC) is -27.58%.
Return on Equity (ROE)1.17
Return on Assets (ROA)0.64
Return on Invested Capital (ROIC)-27.58%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee13.19K
Profits Per Employee-162.88K
Employee Count28
Asset Turnover0.03
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Britannia Life Sciences Inc is 0.3. Britannia Life Sciences Inc’s PEG ratio is -0.81.
PE Ratio0.3
PS Ratio32.95
PB Ratio1.93
Price to Fair Value1.93
Price to FCF-4.65
Price to Operating Cash Flow―
PEG Ratio-0.81
Income Statement
In the last 12 months, Britannia Life Sciences Inc had revenue of 369.28K and earned 7.39M in profits. Earnings per share was -0.03.
Revenue369.28K
Gross Profit27.33K
Operating Income-2.25M
Pretax Income-4.56M
Net Income7.39M
EBITDA-4.39M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -2.62M and capital expenditures -283.04K, giving a free cash flow of -2.90M billion.
Operating Cash Flow-2.62M
Free Cash Flow-2.90M
Free Cash Flow per Share-0.02
Dividends & Yields
Britannia Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.30
52-Week Price Change50.00%
50-Day Moving Average0.10
200-Day Moving Average0.09
Relative Strength Index (RSI)27.83
Average Volume (3m)73.07K
Important Dates
Britannia Life Sciences Inc upcoming earnings date is Aug 4, 2026, After Close (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date―
Financial Position
Britannia Life Sciences Inc as a current ratio of 2.72, with Debt / Equity ratio of ―
Current Ratio2.72
Quick Ratio2.72
Debt to Market Cap0.14
Net Debt to EBITDA1.36
Interest Coverage Ratio-21.19
Taxes
In the past 12 months, Britannia Life Sciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Britannia Life Sciences Inc EV to EBITDA ratio is -1.41, with an EV/FCF ratio of -2.36.
EV to Sales16.73
EV to EBITDA-1.41
EV to Free Cash Flow-2.36
EV to Operating Cash Flow-2.36
Balance Sheet
Britannia Life Sciences Inc has C$7.85M in cash and marketable securities with C$248.56K in debt, giving a net cash position of C$5.99M billion.
Cash & Marketable SecuritiesC$7.85M
Total DebtC$248.56K
Net CashC$5.99M
Net Cash Per ShareC$0.04
Tangible Book Value Per ShareC$0.04
Margins
Gross margin is ―, with operating margin of -609.28%, and net profit margin of 2001.95%.
Gross Margin―
Operating Margin-609.28%
Pretax Margin-1235.00%
Net Profit Margin2001.95%
EBITDA Margin-1189.96%
EBIT Margin-1206.25%
Analyst Forecast
The average price target for Britannia Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.93%
EPS Growth Forecast-575.24%